Latest Acquisition Strategy News

Sultan Resources Ltd (ASX: SLZ) has successfully listed on the US OTCID Market under the code SLZRF, aiming to increase liquidity and attract North American investors. The move supports the company’s strategy to expand its presence in the precious and critical metals sectors.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.

Tuas Limited has reported a robust first half for FY26, with significant revenue and profit growth driven by expanding mobile and broadband subscribers, alongside progress on its strategic M1 acquisition.

Chariot Resources has raised A$2.1 million through a share placement, attracting institutional and sophisticated investors to back its expanding lithium projects in the US and Nigeria. The placement includes free attaching options, pending shareholder approval.

Sultan Resources is advancing plans to list on the US OTC Markets Group, aiming to enhance liquidity and attract North American investors while pursuing strategic acquisitions.

Challenger Limited has lowered its non-binding offer for Pepper Money to $2.25 per share, adjusting for upcoming dividends, marking its final bid amid ongoing negotiations.

Raiz Invest Limited reported a robust half-year performance for the period ending 31 December 2025, with revenue climbing 23.9% and a return to profitability driven by increased customer engagement and funds under management.

FIN Resources has completed the acquisition of the Cabin Lake Gold Project in Canada’s Northwest Territories, securing key permits and preparing for a fully funded drilling campaign starting in March 2026.

Vysarn Limited has reported a record first half for FY26 with revenue hitting $66.8 million and NPBT nearly doubling year-on-year to $10 million. The company reaffirms its full-year $20 million NPBT target, supported by strong industrial and advisory segment growth despite timing challenges in technology projects.

Apiam Animal Health has officially become a wholly owned subsidiary of Adamantem Capital's entities following a scheme of arrangement, with shareholders receiving a special dividend and a mix of cash and shares. The company will soon be delisted from the ASX.

Alfabs Australia reported a 28% revenue rise to $55.6 million in H1 2026, but EBITDA fell due to a $2.8 million Dartbrook mine impact and softer engineering margins. The company is investing heavily in mining hire assets and pursuing a strategic acquisition to drive future growth.

Intelligent Monitoring Group Limited has significantly reduced its half-year loss while increasing revenue and adjusted EBITDA, driven by organic growth and key acquisitions in Australia and New Zealand.